Author:
Shakya Nishi,Sane Shraddha A.,Gupta Suman
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Insect Science,General Veterinary,General Medicine,Parasitology
Reference27 articles.
1. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH (2002) A six-week course of oral fluconazole, in a dose of 200 mg daily for 6 weeks, is a safe and useful treatment for cutaneous leishmaniasis caused by L. major. N Engl J Med 346:891–895
2. Arevalo I, Ward B, Miller R (2001) Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 33:1847–1851
3. Ashutosh GS, Ramesh SS, Goyal N (2005) Use of L. donovani field isolates expressing luciferase reporter gene in in vitro drug screening. Antimicrob Agents Chemother 49:3776–3783
4. Bhatnagar S, Guru PY, Katiyar JC, Srivastava R, Mukherjee A, Akhtar MS, Seth M, Bhaduri AP (1989) Exploration of antileishmanial activity in heterocycles; results of their in vivo and in vitro bioevaluations. Indian J Med Res 89:439–444
5. Buates S, Matlashewski G (1999) Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 179:1485–1494
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献